- Home
- HUT vs TERN Comparison
HUT vs TERN Comparison
Compare HUT & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUT | TERN |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HUT | TERN |
|---|---|---|
| Price | $61.71 | $34.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 10 |
| Target Price | ★ $54.29 | $48.60 |
| AVG Volume (30 Days) | ★ 5.1M | 2.1M |
| Earning Date | 03-02-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | ★ $178,318,000.00 | N/A |
| Revenue This Year | $74.79 | N/A |
| Revenue Next Year | $116.78 | N/A |
| P/E Ratio | $34.10 | ★ N/A |
| Revenue Growth | ★ 5.60 | N/A |
| 52 Week Low | $10.04 | $1.87 |
| 52 Week High | $66.07 | $48.26 |
Technical Indicators
Market Signals| Indicator | HUT | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 61.64 | 43.72 |
| Support Level | $53.26 | $33.60 |
| Resistance Level | $66.07 | $35.46 |
| Average True Range (ATR) | 5.01 | 1.93 |
| MACD | 0.03 | -0.55 |
| Stochastic Oscillator | 74.71 | 23.04 |
Price Performance
Historical ComparisonAbout HUT Hut 8 Corp.
Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.